Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.
Company Details
- Employees
- 34
- Founded
- -
- Address
- 696 Roosevelt Drive, 20.06 Bioescalator Innovation Building,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Oxford, Oxfordshire
Infinitopes Questions
Infinitopes's LinkedIn profile is https://uk.linkedin.com/company/infinitopes
Infinitopes has
34 employees.
View email and phone details for 34
employees at Infinitopes.
Infinitopes's industry is
Biotechnology Research
Infinitopes's top competitors are
Draupnir Bio,
Quotient Therapeutics,
Cumulus Oncology,
Relation,
Adcytherix,
Alethiomics,
Bioescalator,
Artica Therapeutics,
Bioptimus,
Expressionedits.
Infinitopes's categories are Biotechnology Research
Infinitopes's founding year is 2021
